BPC-157 Benefits Being Studied Current laboratory investigations continue examining numerous BPC-157 benefits across multiple scientific disciplines
3.4.4 Alkaloids: comprehensive miRNA biogenesis modulation Berberine targets multiple oncogenic miRNAs, including miR-21 (5070% reduction in HCT116 cells), miR-23a (2.5-fold increase in hepatoma cells), and suppression of the miR-1792 cluster in multiple myeloma
PMID 24385169
Systemic and metabolic conditions such as diabetes, obesity, multiple sclerosis, rheumatoid arthritis, lupus erythematosus, ankylosing spondylitis, as well as Alzheimers disease, Parkinsons disease, chronic depression and autism spectrum disorders also become a growing health problem [1,2,3,4,5,6]